EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access

Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone–Salmeterol to Treat Chronic Obstructive Pulmonary Disease

William B Feldman iD, Aaron S Kesselheim iD, Jerry Avorn, Massimiliano Russo iD, Shirley V Wang iD

Annals of Internal Medicine · 2023

DOI: 10.7326/m23-0615 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Annals of Internal Medicine, 2023. Verfasst von William B Feldman und 4 weiteren Autor:innen. Beteiligte Einrichtung: Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Division of Pulmonary a…. Hauptthemen laut MEDLINE: Pulmonary Disease, Chronic Obstructive, Asthma, Pneumonia. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pulmonary Disease, Chronic ObstructiveAsthmaPneumoniaAdultHumansFluticasone-Salmeterol Drug CombinationBronchodilator AgentsCohort StudiesSalmeterol XinafoateFluticasoneAdministration, InhalationDrug CombinationsAndrostadienes

Substanzen

Fluticasone-Salmeterol Drug CombinationBronchodilator AgentsSalmeterol XinafoateFluticasoneDrug CombinationsAndrostadienes

Autor:innen und Institutionen

  • Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's…
  • Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts (A.S.K., J.A.…
  • Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, Boston, Massachusetts (M.R., S.V.W.).

ORCID-Profile: William B Feldman, Aaron S Kesselheim, Massimiliano Russo, Shirley V Wang

Förderung

  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute

Zitieren

APA

Feldman, W. B., Kesselheim, A. S., Avorn, J., Russo, M., & Wang, S. V. (2023). Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone–Salmeterol to Treat Chronic Obstructive Pulmonary Disease. Annals of Internal Medicine. https://doi.org/10.7326/m23-0615

Vancouver

Feldman WB, Kesselheim AS, Avorn J, Russo M, Wang SV. Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone–Salmeterol to Treat Chronic Obstructive Pulmonary Disease. Annals of Internal Medicine. 2023. doi:10.7326/m23-0615

BibTeX
@article{Feldman2023,
  author = {Feldman, William B and Kesselheim, Aaron S and Avorn, Jerry and Russo, Massimiliano and Wang, Shirley V},
  title = {Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone–Salmeterol to Treat Chronic Obstructive Pulmonary Disease},
  journal = {Annals of Internal Medicine},
  year = {2023},
  doi = {10.7326/m23-0615}
}
Kostenlos starten →